Full Length Research Paper
Y. Dhanusha Yesudhas
Department of Bioinformatics, Karunya University, Coimbatore India.
Type 2 diabetes mellitus (T2DM) is the most common metabolic disease in theworld, reaching epidemic proportions. PPARGC1A mRNA expression is reduced in islets from patients with diabetes 2 and it is influenced by both genetic and epigenetic factor. The epigenetic modification, results as a two fold increase in DNA methylation of the PGC1A promoter of diabetes. This two fold increase in DNA methylation is due to the DNA methyl transferase1 (DNMT1) enzyme. In the present study, methylation activity of DNMT 1 enzyme was inhibited with suitable methylation inhibitors which led to the decrease of the hypermethylation of PGC 1 alpha protein. The interaction study of this modified DNMT1 with PGC 1 alpha leads to the new way of drug discovery in type 2 diabetes.
Key words: Type 2 diabetes mellitus (T2DM), methyl transferase1 (DNMT1), epigenetic modification.
Akio K, Tibor A, Rauch b, Ivan T, Hsun T (2009). "Insulin Gene Expression Is Regulated by DNA Methylation” PLoS ONE. 9: 6953.
Goffin J, Eisenhauer E (2002). DNA methyltransferase inhibitors-state of the art. Ann. Oncol. 13: 1699-1716.
Ling C, Del Guerra S, Lupi R, Ronn T, Granhall C, Luthman H, Masiello P, Groop G Del S (2008). Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetol. 51: 615-622.
Long-Cheng L, Rajvir D (2002). MethPrimer:designing primers for methylation PCRs. Bioinformatics. 18:1427-1431.
Marcotte E, Pellegrini M, RiceD, YeatesT, Eisenberg D (1999). Detecting protein function and protein-protein interactions from genome sequences. Science. 285: 751-753
Reik W, Dean W, Walter J (2001). Epigenetic reprogramming in mammalian development. Science. 10:1089-93.
Puigserver P, Spiegelman B (2003). Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endoc. Rev. 24: 78-90.
Puigserver P, Rhee J, Donovan J, Walkey C, Yoon J, Kitamura Y, Altomonte J, Accili D, Spiegelman B (2003). Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 423: 550-555.
|APA||(2013). Epigenetic regulation of PGC1 α in human type 2 diabetes. Journal of Biophysics and Structural Biology, 5(1), 1-9.|
|Chicago||Y. Dhanusha Yesudhas. "Epigenetic regulation of PGC1 α in human type 2 diabetes." Journal of Biophysics and Structural Biology 5, no. 1 (2013): 1-9.|
|MLA||Y. Dhanusha Yesudhas. "Epigenetic regulation of PGC1 α in human type 2 diabetes." Journal of Biophysics and Structural Biology 5.1 (2013): 1-9.|